Add-on therapy was linked to faster immune tolerance and fewer treated bleeds in a small study of children with hemophilia A.
When living with bleeding disorders, sometimes you don’t get to finish healing before the next thing arrives, writes columnist.
Alvotech and Lotus are partnering on AVT87, a proposed biosimilar that could expand hemophilia A treatment options in the U.S ...
Columnist Joe MacDonald asked his oldest son what he'd change about people's understanding of hemophilia. Here's what Julian, 30, had to say.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results